Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05591703 · ClinicalTrials.gov registry record
Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study
A clinical trial, sponsored by Spark Biomedical.
- Completed
- Registry status
- 32
- Enrollment target
NCT05591703 is a clinical trial that has completed, run by Spark Biomedical. The registered enrollment target is 32 participants.
The verdict
NCT05591703 has completed, sponsored by Spark Biomedical.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
This is a prospective, observational, longitudinal study to assess clinical outcomes in the 12-months following participants' exit from protocol SBM-OWP-03, Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder (RESTORE; ClinicalTrials.gov Identifier: NCT05053503). Clinical outcome scores will be collected at study exit from protocol SBM-OWP-03, 1 month, 3 months, 6 months, 9 months, and 12 months after study exit from protocol SBM-OWP-03.
Interventions
- BEHAVIORAL Clinical Outcomes and Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-11-21 |
| Est. Completion | 2025-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05591703
The ClinicalTrials.gov registry entry for NCT05591703 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spark Biomedical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clinical Outcomes and Questionnaires is the first listed.
NCT05591703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05591703 about?
NCT05591703 is a clinical study titled "Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study". This is a prospective, observational, longitudinal study to assess clinical outcomes in the 12-months following participants' exit from protocol SBM-OWP-03, Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder (RESTORE; ClinicalTrials.gov Identifi...
What is the current status of trial NCT05591703?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2022-11-21. Estimated completion is 2025-01-31.
What interventions are being tested in trial NCT05591703?
The interventions under investigation include: Clinical Outcomes and Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT05591703?
This trial is sponsored by Spark Biomedical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.